• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

PET-CT for the Management of Cancer Patients: a Review of the Existing Evidence

IAEA Human Health Series No. 45

English STI/PUB/1993 ¦ 978-92-0-118622-5

79 pages ¦ € 50.00 ¦ Date published: 2023

Download PDF (2.84 MB)

EPUB format available (3.87 MB)

Description

While the use of positron emission tomography–computed tomography (PET–CT) is a standard of care in oncological practice in many developed countries, it is still limited in many low to middle income nations. To make reliable information more widely available, the IAEA convened an expert consultant group to review, based on the most recent developments of PET radiopharmaceuticals, Human Health Series No. 9, Appropriate Use of FDG-PET for the Management of Cancer Patients. This, the resulting publication, provides up to date recommendations on the optimal use of PET–CT imaging procedures in oncology. It is written for policy makers and decision makers who allocate resources dedicated to the health care system, a critical issue in the development of nuclear medicine in low and middle income countries. It will also benefit medical imaging practitioners as well as referring physicians.

More Information on reusing IAEA copyright material.

Keywords

IAEA Human Health, Positron Emission Tomography, Computed Tomography PET-CT, Management, Cancer Patients, Review, Existing Evidence, Nuclear Medicine, Oncological Practice, Data Recommendations, PET-CT Imaging Procedures, FDG-PET, Guidelines, Health Care Providers, Policy Makers, Good Practices, Clinical Scenarios, Primary Tumours, Central Nervous System, Diagnosis, Staging, Response Evaluation, Recurrence, Follow-up, Radiation Therapy Planning, Non-Small Cell Lung Cancer, NSCLC, Small Cell Lung Cancer, SCLC, Mesothelioma, Breast Cancer, Oesophageal Cancer, Gastric Cancer, Bladder Cancer, Prostate Cancer, Endometrial Cancer, Myeloma, Gastrointestinal and Pancreatic Neuroendocrine Tumours, GEP-NETs, Germinal Tumour, Medullary Thyroid Carcinoma, Cancer of Unknown Primary, Low and middle Income Countries

Related publications

Stay in touch

Newsletter